Is DiaSorin SpA halal to invest in?

As of August 2026, DiaSorin SpA DIAS.VI is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is DiaSorin SpA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes DiaSorin SpA using these criteria to determine its compliance status.

Can Muslims buy shares of DiaSorin SpA?

Muslim investors may consider investing in DiaSorin SpA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is DiaSorin SpA classified as HALAL?

Musaffa determines the Shariah status of DiaSorin SpA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for DiaSorin SpA updated?

The Shariah compliance status of DiaSorin SpA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like DiaSorin SpA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of DiaSorin SpA?

You can check the latest Shariah compliance status of DiaSorin SpA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

DiaSorin SpA DIAS.VI

Last Updated: Aug 07, 12:00 AM·WBAG

DIAS.VI Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, DiaSorin SpA is classified as halal.

HALAL

Report Source: undefined Quarter Report

DiaSorin SpA. Stock Analysis DIAS.VI

Austria Health Care Mid Cap

DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. The company is headquartered in Saluggia, Vercelli and currently employs 3,272 full-time employees. The company went IPO on 2007-07-19. The firm specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The firm develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. The company operates through ELISA immunodiagnostic business portfolio.